According to Research, the global market for Drugs for Heartworm Disease should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Drugs for Heartworm Disease market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Drugs for Heartworm Disease market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Spray Type segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Animal Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Drugs for Heartworm Disease include Boehringer Ingelheim, Wellmark International, Inc, HEARTGARD Plus, Merck Animal Health (Merck & Co., Inc.), Pfizer Inc, Bayer AG, Mylan N.V, Ceva Sante Animale S.A and PetCareRx, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Drugs for Heartworm Disease. Report Highlights:
(1) Global Drugs for Heartworm Disease market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Drugs for Heartworm Disease market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Drugs for Heartworm Disease market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Drugs for Heartworm Disease segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Drugs for Heartworm Disease segment by type and by application and regional segment by type and by application.
(6) Drugs for Heartworm Disease industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Spray Type
Take Type
Others
Market segment by application, can be divided into
Animal Hospital
Veterinary Clinic
Others
Market segment by players, this report covers
Boehringer Ingelheim
Wellmark International, Inc
HEARTGARD Plus
Merck Animal Health (Merck & Co., Inc.)
Pfizer Inc
Bayer AG
Mylan N.V
Ceva Sante Animale S.A
PetCareRx
Ecto Development Corporation
1 Market Overview
1.1 Product Overview and Scope of Drugs for Heartworm Disease
1.2 Global Drugs for Heartworm Disease Market Size and Forecast
1.3 China Drugs for Heartworm Disease Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Drugs for Heartworm Disease Share in Global Market, 2018-2029
1.4.2 Drugs for Heartworm Disease Market Size: China VS Global, 2018-2029
1.5 Drugs for Heartworm Disease Market Dynamics
1.5.1 Drugs for Heartworm Disease Market Drivers
1.5.2 Drugs for Heartworm Disease Market Restraints
1.5.3 Drugs for Heartworm Disease Industry Trends
1.5.4 Drugs for Heartworm Disease Industry Policy
2 Global Competitive Situation by Company
2.1 Global Drugs for Heartworm Disease Revenue by Company (2018-2023)
2.2 Global Drugs for Heartworm Disease Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Drugs for Heartworm Disease Concentration Ratio
2.4 Global Drugs for Heartworm Disease Mergers & Acquisitions, Expansion Plans
2.5 Global Drugs for Heartworm Disease Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Drugs for Heartworm Disease Revenue by Company (2018-2023)
3.2 China Drugs for Heartworm Disease Drugs for Heartworm Disease Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Drugs for Heartworm Disease, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Drugs for Heartworm Disease Industry Chain
4.2 Drugs for Heartworm Disease Upstream Analysis
4.3 Drugs for Heartworm Disease Midstream Analysis
4.4 Drugs for Heartworm Disease Downstream Analysis
5 Sights by Type
5.1 Drugs for Heartworm Disease Classification
5.1.1 Spray Type
5.1.2 Take Type
5.1.3 Others
5.2 By Type, Global Drugs for Heartworm Disease Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Drugs for Heartworm Disease Revenue, 2018-2029
6 Sights by Application
6.1 Drugs for Heartworm Disease Segment by Application
6.1.1 Animal Hospital
6.1.2 Veterinary Clinic
6.1.3 Others
6.2 By Application, Global Drugs for Heartworm Disease Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Drugs for Heartworm Disease Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Drugs for Heartworm Disease Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Drugs for Heartworm Disease Market Size, 2018-2029
7.3 North America
7.3.1 North America Drugs for Heartworm Disease Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Drugs for Heartworm Disease Market Size Market Share
7.4 Europe
7.4.1 Europe Drugs for Heartworm Disease Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Drugs for Heartworm Disease Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Drugs for Heartworm Disease Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Drugs for Heartworm Disease Market Size Market Share
7.6 South America
7.6.1 South America Drugs for Heartworm Disease Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Drugs for Heartworm Disease Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Drugs for Heartworm Disease Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Drugs for Heartworm Disease Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Drugs for Heartworm Disease Market Size, 2018-2029
8.3.2 By Company, U.S. Drugs for Heartworm Disease Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Drugs for Heartworm Disease Market Size, 2018-2029
8.4.2 By Company, Europe Drugs for Heartworm Disease Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Drugs for Heartworm Disease Market Size, 2018-2029
8.5.2 By Company, China Drugs for Heartworm Disease Revenue Market Share, 2018-2023
8.5.3 By Type, China Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Drugs for Heartworm Disease Market Size, 2018-2029
8.6.2 By Company, Japan Drugs for Heartworm Disease Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Drugs for Heartworm Disease Market Size, 2018-2029
8.7.2 By Company, South Korea Drugs for Heartworm Disease Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Drugs for Heartworm Disease Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Drugs for Heartworm Disease Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Drugs for Heartworm Disease Market Size, 2018-2029
8.9.2 By Company, India Drugs for Heartworm Disease Revenue Market Share, 2018-2023
8.9.3 By Type, India Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Drugs for Heartworm Disease Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Drugs for Heartworm Disease Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Drugs for Heartworm Disease Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position
9.1.2 Boehringer Ingelheim Company Profile and Main Business
9.1.3 Boehringer Ingelheim Drugs for Heartworm Disease Models, Specifications and Application
9.1.4 Boehringer Ingelheim Drugs for Heartworm Disease Revenue and Gross Margin, 2018-2023
9.1.5 Boehringer Ingelheim Recent Developments
9.2 Wellmark International, Inc
9.2.1 Wellmark International, Inc Company Information, Head Office, Market Area and Industry Position
9.2.2 Wellmark International, Inc Company Profile and Main Business
9.2.3 Wellmark International, Inc Drugs for Heartworm Disease Models, Specifications and Application
9.2.4 Wellmark International, Inc Drugs for Heartworm Disease Revenue and Gross Margin, 2018-2023
9.2.5 Wellmark International, Inc Recent Developments
9.3 HEARTGARD Plus
9.3.1 HEARTGARD Plus Company Information, Head Office, Market Area and Industry Position
9.3.2 HEARTGARD Plus Company Profile and Main Business
9.3.3 HEARTGARD Plus Drugs for Heartworm Disease Models, Specifications and Application
9.3.4 HEARTGARD Plus Drugs for Heartworm Disease Revenue and Gross Margin, 2018-2023
9.3.5 HEARTGARD Plus Recent Developments
9.4 Merck Animal Health (Merck & Co., Inc.)
9.4.1 Merck Animal Health (Merck & Co., Inc.) Company Information, Head Office, Market Area and Industry Position
9.4.2 Merck Animal Health (Merck & Co., Inc.) Company Profile and Main Business
9.4.3 Merck Animal Health (Merck & Co., Inc.) Drugs for Heartworm Disease Models, Specifications and Application
9.4.4 Merck Animal Health (Merck & Co., Inc.) Drugs for Heartworm Disease Revenue and Gross Margin, 2018-2023
9.4.5 Merck Animal Health (Merck & Co., Inc.) Recent Developments
9.5 Pfizer Inc
9.5.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
9.5.2 Pfizer Inc Company Profile and Main Business
9.5.3 Pfizer Inc Drugs for Heartworm Disease Models, Specifications and Application
9.5.4 Pfizer Inc Drugs for Heartworm Disease Revenue and Gross Margin, 2018-2023
9.5.5 Pfizer Inc Recent Developments
9.6 Bayer AG
9.6.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
9.6.2 Bayer AG Company Profile and Main Business
9.6.3 Bayer AG Drugs for Heartworm Disease Models, Specifications and Application
9.6.4 Bayer AG Drugs for Heartworm Disease Revenue and Gross Margin, 2018-2023
9.6.5 Bayer AG Recent Developments
9.7 Mylan N.V
9.7.1 Mylan N.V Company Information, Head Office, Market Area and Industry Position
9.7.2 Mylan N.V Company Profile and Main Business
9.7.3 Mylan N.V Drugs for Heartworm Disease Models, Specifications and Application
9.7.4 Mylan N.V Drugs for Heartworm Disease Revenue and Gross Margin, 2018-2023
9.7.5 Mylan N.V Recent Developments
9.8 Ceva Sante Animale S.A
9.8.1 Ceva Sante Animale S.A Company Information, Head Office, Market Area and Industry Position
9.8.2 Ceva Sante Animale S.A Company Profile and Main Business
9.8.3 Ceva Sante Animale S.A Drugs for Heartworm Disease Models, Specifications and Application
9.8.4 Ceva Sante Animale S.A Drugs for Heartworm Disease Revenue and Gross Margin, 2018-2023
9.8.5 Ceva Sante Animale S.A Recent Developments
9.9 PetCareRx
9.9.1 PetCareRx Company Information, Head Office, Market Area and Industry Position
9.9.2 PetCareRx Company Profile and Main Business
9.9.3 PetCareRx Drugs for Heartworm Disease Models, Specifications and Application
9.9.4 PetCareRx Drugs for Heartworm Disease Revenue and Gross Margin, 2018-2023
9.9.5 PetCareRx Recent Developments
9.10 Ecto Development Corporation
9.10.1 Ecto Development Corporation Company Information, Head Office, Market Area and Industry Position
9.10.2 Ecto Development Corporation Company Profile and Main Business
9.10.3 Ecto Development Corporation Drugs for Heartworm Disease Models, Specifications and Application
9.10.4 Ecto Development Corporation Drugs for Heartworm Disease Revenue and Gross Margin, 2018-2023
9.10.5 Ecto Development Corporation Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|